Single-Donor and Pooling Strategies for Fecal Microbiota Transfer Product Preparation in Ulcerative Colitis: A Systematic Review and Meta-analysis
Open Access
- 24 February 2023
- journal article
- review article
- Published by Wolters Kluwer Health in Clinical and Translational Gastroenterology
- Vol. 14 (5) , e00568
Abstract
INTRODUCTION: Patients with ulcerative colitis (UC) have a less diverse microbiome than healthy subjects. Multiple studies have evaluated fecal microbiota transfer (FMT) in these patients using different methods of product preparation, doses, and routes of administration. A systematic review and meta-analysis was performed to compare the efficacy of single-donor (SDN) and multidonor (MDN) strategies for product preparation. METHODS: Systematic searches were performed in Web of Science, Scopus, PubMed, and Orbit Intelligence for studies comparing FMT products manufactured using SDN or MDN strategies to placebo in patients with UC. Fourteen controlled studies were selected for meta-analysis (10 randomized and 4 nonrandomized). The treatment response was assessed by using fixed- and random-effects models, and the significance of the indirect difference between the interventions was assessed using a network approach. RESULTS: Considering all 14 studies, MDN and SDN were superior to placebo in terms of treatment response (risk ratios [RRs]: 4.41 and 1.57, respectively [P ≤ 0.001 for both]), and MDN was superior to SDN (RR: 2.81, P = 0.005). Meta-analysis of the 10 studies with high quality of evidence showed that MDN was superior to SDN in terms of treatment response (RR: 2.31, P = 0.042). Results were identical for both models. DISCUSSION: There was a significant clinical benefit (remission) for patients with UC who received FMT with products manufactured by MDN strategies. Reduction of donor effect may lead to a gain in microbial diversity that could improve response to treatment. These results may have implications in the treatment approach of other diseases amenable to microbiome manipulation. JOURNAL/cltg/04.03/01720094-202305000-00002/2FFU1/v/2025-05-05T152039Z/r/image-tiffKeywords
This publication has 66 references indexed in Scilit:
- P398. An Open-label, Pilot Study to Assess Feasibility and Safety of Fecal Microbiota Transplantation in Patients with Mild-Moderate Ulcerative Colitis: preliminary results.Journal of Crohn's and Colitis, 2015
- Fecal Microbial Transplant Via Nasogastric Tube for Active Pediatric Ulcerative ColitisJournal of Pediatric Gastroenterology and Nutrition, 2015
- Reduce dimension or reduce weights? Comparing two approaches to multi‐arm studies in network meta‐analysisStatistics in Medicine, 2014
- Alteration of Intestinal Dysbiosis by Fecal Microbiota Transplantation Does not Induce Remission in Patients with Chronic Active Ulcerative ColitisInflammatory Bowel Diseases, 2013
- Safety, Tolerability, and Clinical Response After Fecal Transplantation in Children and Young Adults With Ulcerative ColitisJournal of Pediatric Gastroenterology and Nutrition, 2013
- Network meta‐analysis, electrical networks and graph theoryResearch Synthesis Methods, 2012
- Indirect and mixed‐treatment comparison, network, or multiple‐treatments meta‐analysis: many names, many benefits, many concerns for the next generation evidence synthesis toolResearch Synthesis Methods, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tablesJournal of Clinical Epidemiology, 2011
- Network meta‐analysis for indirect treatment comparisonsStatistics in Medicine, 2002